![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 36, 25899-25905, September 3, 1999
From the It has been proposed that in rat and murine
tissues glucosidase II (GII) is formed by two subunits, GII Glucosidase II (GII)1
plays a pivotal role in the processing of N-oligosaccharides
in the endoplasmic reticulum (ER). The oligosaccharide transferred from
the dolichol-P-P-derivative to Asn residues in nascent polypeptide
chains (Glc3Man9GlcNAc2) is first
deglucosylated by glucosidase I (GI), which removes the more external
glucose unit, and then by glucosidase II (GII), which excises both
remaining glucose units. The UDP-Glc:glycoprotein glucosyltransferase
(GT) then transfers a single glucose unit to glucose-free
oligosaccharides (1, 2). According to the model proposed for the
quality control of glycoprotein folding in mammalian cells,
monoglucosylated oligosaccharides formed either by partial
deglucosylation of the transferred compound or by GT-mediated
reglucosylation are recognized by two ER lectins, membrane-bound
calnexin or its soluble homolog calreticulin (3). Further
deglucosylation of the oligosaccharides by GII liberates the
glycoproteins from their lectin anchors. The oligosaccharides are then
reglucosylated by GT and thus recognized again by the lectins, only
when linked to misfolded protein moieties as it has been found that GT
only glucosylates glycoproteins not displaying their proper tertiary
structures (2, 4). The deglucosylation-reglucosylation cycle continues
until proper glycoprotein folding is achieved.
The calnexin/calreticulin-monoglucosylated glycoprotein interaction was
called quality control of glycoprotein folding as it was found to be
one of the several existing alternative mechanisms by which cells
retain misfolded species in the ER and eventually transport them to the
cytosol where they are degraded in the proteasomes (5). In addition,
the above mentioned interaction facilitates glycoprotein folding by
preventing aggregation and formation of non-native disulfide bonds (6,
7). As a result of this interaction, a decrease in glycoprotein folding
rate but an increase in folding efficiency were observed (6).
All evidence for the proposed mechanism of quality control of
glycoprotein folding was derived from experiments performed in
mammalian cell systems (3), but presumably a similar mechanism is
operative in Schizosaccharomyces pombe as this yeast
expresses a GT activity and a calnexin homolog (8-11). In
addition, it has been reported that the oligosaccharide
transferred to nascent polypeptides in S. pombe is
Glc3Man9GlcNAc2, the same as in
most eukaryotic cells, and that this compound is processed in the ER to
Man9GlcNAc2, thus indicating the presence of
both GI and GII activities (12). We have recently reported that
GT-mediated formation of monoglucosylated oligosaccharides is essential
for S. pombe viability under conditions of severe ER stress
such as underglycosylation of glycoproteins caused by the
alg6 mutation and high temperature
(Man9GlcNAc2 and not
Glc3Man9GlcNAc2 is transferred in
alg6 mutants) (13). It was proposed that folding of a
glycoprotein involved in cell wall formation was affected in
gpt1/alg6 double mutants as the wild type phenotype could be
restored not only upon transfection with a GT-encoding expression
vector but also in a hyperosmotic growth medium (1 M
sorbitol). No evidence was presented, however, indicating that
monoglucosylated oligosaccharides actually facilitated glycoprotein
folding in this yeast.
Purification of GII from rat and murine tissues yielded two tightly
bound polypeptides (named GII The purpose of work reported here is to present genetic support for the
proposed heterodimeric structure of GII as well as for the occurrence
of monoglucosylated oligosaccharide-mediated glycoprotein folding
facilitation in low eukaryote cells.
Strains and Medium--
Escherichia coli DH5 Identification and Disruption of the GII
For disrupting the gls2 RNA Procedures--
Cells were grown under normal conditions (YE
medium at 28 °C), and RNA was extracted from cells in exponential
phase of growth at the same optical density and submitted to Northern
blotting as performed previously (10). Probes used were DNA fragments synthesized by PCR using a genomic DNA as template and had 1004 and 973 base pairs from BiP- and actin-encoding genes, respectively.
DNA Procedures--
Standard DNA manipulations and hybridization
conditions were carried out as described (21).
Materials--
[14C]Glucose (250 Ci/mol) and
[35S]Met plus [35S]Cys (>1000 Ci/mmol,
EasyTag Express protein labeling mix) were from NEN Life Science Products. Jack bean Substrates and
Standards--
[glucose-14C]Glc1Man7GlcNAc,
[glucose-14C]Glc1Man8GlcNAc,[glucose-14C]Glc1Man9GlcNAc,
[glucose-14C]Glc3Man9GlcNAc,
[glucose-14C]Glc2Man9GlcNAc,
[glucose-14C]Glc1Man4GlcNAc,
[glucose-14C]Glc1Man5GlcNAc,
[14C]Man8GlcNAc, and
[14C]Man9GlcNAc were prepared as described
previously (8). Treatment of
[glucose-14C]Glc2Man9GlcNAc
with jack bean Methods--
Strong acid hydrolysis and treatment of
oligosaccharides with jack bean Construction and Genetic Analysis of gls2 Cell-free Biochemical Characterization of gls2 In Vivo Biochemical Characterization of Mutants--
Wild type and
both gls2
A different oligosaccharide pattern was obtained in the case of the
mutant strains; only two compounds that migrated as
Glc2Man9GlcNAc and
Glc1Man9GlcNAc standards appeared in the
chromatogram. A higher proportion of the faster migrating compound was
observed in gls2
On the other hand, an
From results shown in Figs. 1-3, it was concluded that gls2
No differences in the growth rates of wild type and gls2 Cells Defective in Monoglucosylated Oligosaccharide Formation
Accumulate Glycoproteins Bearing ER-specific Oligosaccharides--
It
has been reported that in S. pombe wild type cells
Glc3Man9GlcNAc2 is processed
in the ER mainly to Man9GlcNAc2 (but formation of small amounts of Man8GlcNAc2 was also
observed) and further elongated in the Golgi by the addition of mannose
and galactose units (12, 13, 20). It may be speculated that if
monoglucosylated oligosaccharides facilitated glycoprotein folding,
mutants in which formation of those compounds were totally
(gls2
To confirm that indeed misfolding of glycoproteins resulted in the
accumulation of protein species bearing ER-specific oligosaccharides, wild type cells were incubated as above but in the presence of 5 mM dithiothreitol. It has been shown that this reagent
prevents correct folding of disulfide bond-containing glycoproteins
(20, 24, 25). Contrary to what was found on incubation in the absence of dithiothreitol (Fig. 4A), in the presence of the drug
wild type cells accumulated Man9GlcNAc2-
and Man8GlcNAc2-containing glycoproteins (Fig.
4D). Three oligosaccharides larger than the above mentioned
compounds were observed. They probably correspond to glycoproteins not
having disulfide linkages.
The Unfolded Protein Response in Wild Type, gls2
We determined by Northern blotting analysis the amounts of the
mRNAs coding for BiP, the more abundant ER chaperone, and for a
constitutively expressed protein (actin) present in wild type, gls2
It may be concluded, therefore, that under normal growth conditions
misfolded proteins accumulated in the ER of S. pombe cells in which absolutely no monoglucosylated oligosaccharides
(gls2 Processing of Carboxypeptidase Y (CPY) in gls2
In Fig. 6A, the relative
intensities of the CPY fragment of the 30-min chase samples of either
wild type or gls2 As mentioned above, it has been proposed that GII is a heterodimer
composed by catalytic (GII We herein present genetic evidence for the heterodimeric structure of
GII. Genes coding for either GII Retention of two glucose units in protein-linked oligosaccharides is
not expected to cause misfolding of glycoproteins per se as
it has been determined that oligosaccharides are mainly processed in
S. pombe ER to Man9GlcNAc2 and that
the tertiary structure of this compound is identical whether it has
one, two, or no glucoses (12, 30). In addition, GII Formation of monoglucosylated oligosaccharides decreased the folding
rate but increased the folding efficiency in S. pombe, the
same as in mammalian cells, because monitoring of CPY processing indicated that this glycoprotein arrived early but in diminished amounts to the vacuoles of gls2 No induction of BiP mRNA was observed in S. cerevisiae
GII-deficient mutants grown under non-stressed conditions (34, 35). This result, as well as the absence of GT, the sensor of misfolded protein conformations, from those cells and the existence of a calnexin
homolog with striking structural variations in the domain that
recognizes monoglucosylated oligosaccharides (P-domain) (8, 34, 36, 37)
casts doubts on the occurrence of a quality control mechanism of
glycoprotein folding in S. cerevisiae similar to that
described for mammalian cells.
*
This work was supported by National Institutes of Health
Grant GM44500, by Howard Hughes Medical Institute Grant 75197-553502, by the University of Buenos Aires, and by the Argentine Federal Government (Consejo Nacional de Investigaciones Cientificas y Técnias and Agencia Nacional de Promocion Cientifica y
Tecnologia).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Doctoral Fellow.
¶
Post-doctoral Fellow.
**
A Jane Childs Coffin Post-doctoral Fellow.
The abbreviations used are:
GII, glucosidase II;
BiP, binding protein;
CPY, carboxypeptidase Y;
Endo H, endo-
Genetic Evidence for the Heterodimeric Structure of Glucosidase
II
THE EFFECT OF DISRUPTING THE SUBUNIT-ENCODING GENES ON
GLYCOPROTEIN FOLDING*
§,
¶,
**, and

Instituto de Investigaciones
Bioquímicas Fundación Campomar, Antonio Machado 151, 1405 Buenos Aires, Argentina and the
Department of Cell
Biology, Yale University School of Medicine,
New Haven, Connecticut 06520-8002
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
and
GII
, respectively, responsible for the catalytic activity and the
retention of the enzyme in the endoplasmic reticulum (ER). To test this
proposal we disrupted genes (gls2
+ and
gls2
+) encoding GII
and GII
homologs
in Schizosaccharomyces pombe. Both mutant cells
(gls2
and gls2
) were completely devoid of GII activity in cell-free assays. Nevertheless,
N-oligosaccharides formed in intact
gls2
cells were identified as
Glc2Man9GlcNAc2 and
Glc2Man8GlcNAc2, whereas
gls2
cells formed, in addition, small amounts of
Glc1Man9GlcNAc2. It is suggested
that this last compound was formed by GII
transiently present in the
ER. Monoglucosylated oligosaccharides facilitated glycoprotein folding
in S. pombe as mutants, in which formation of
monoglucosylated glycoproteins was completely (gls2
) or
severely (gls2
and
UDP-Glc:glycoprotein:glucosyltransferase null) diminished, showed ER
accumulation of misfolded glycoproteins when grown in the absence of
exogenous stress as revealed by (a) induction of binding
protein-encoding mRNA and (b) accumulation of
glycoproteins bearing ER-specific oligosaccharides. Moreover, the same
as in mammalian cell systems, formation of monoglucosylated oligosaccharides decreased the folding rate and increased the folding
efficiency of glycoproteins as pulse-chase experiments revealed that
carboxypeptidase Y arrived at a higher rate but in decreased amounts to
the vacuoles of gls2
than to those of wild type cells.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
and GII
) that could not be
separated by procedures commonly used for enzyme purification without
loss of the enzymatic activity. Subunit GII
(a 104-kDa soluble
protein) had a certain homology to other glucosidases and no ER
retrieval signal at its C terminus, whereas this last feature was found
in subunit GII
, a 58-kDa soluble polypeptide with no sequence
similarity to other proteins (14, 15). It was proposed that GII
was
GII catalytic subunit, whereas GII
was responsible for its ER
retention, but no actual evidence for this proposal was presented. The
proposal remained controversial, however, as no such dimeric structure
was found in GII purified from pig liver and kidney and from plant
tissues (16-18). Moreover, although a GII
homolog devoid of an ER
retrieval sequence is encoded in the Saccharomyces
cerevisiae genome, no protein with significant homology to GII
and having an ER retrieval sequence at its C terminus is encoded in the
DNA of this budding yeast (14).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
was
used for cloning procedures. E. coli XL1-Blue MRF' and XLOLR
(Stratagene) were used for phage screening and plasmid excision,
respectively. The S. pombe wild type strains used for
disrupting gls2
+ and
gls2
+ genes were h90,
ura4-D18, ade6-M216, leu1-32, and
h
, ura4-D18, ade6-M210,
leu1-32, respectively. S. pombe gpt1 mutant was
described previously (9). Bacteria were grown in LB medium, 0.5% NaCl,
1% tryptone (Difco), 0.5% yeast extract (Difco), and 100 µg/ml
ampicillin and 40 µg/ml kanamycin if necessary, or in the same medium
supplemented with 0.2% maltose and 10 mM
MgSO4. S. pombe was grown in YE medium (3%
glucose, 0.5% yeast extract supplemented with adenine). The minimal
medium used, supplemented with Ade and Leu, was described before
(19).
- and GII
-encoding
Genes (gls2
+ and gls2
+,
Respectively)--
Identification and disruption of the
gls2
+ gene was performed, and the resulting
mutant strain (gls2
) was genetically characterized as
described before for construction of the gls2/alg6 double
mutant (13, 20). To sequence gls2
+ gene to
its C-terminal end, the 998-bp fragment used for
gls2
+ disruption (20) was used as probe for
screening S. pombe genomic DNA library constructed in
ZAP
(10). Five independent phages were isolated, and insert-containing
plasmids (pBK-CMV) were recovered from them. All plasmids had inserts
of about 4,500 bp. Sequencing them revealed that GII
ended with
PQLFLV at its C terminus.
gene, exact primers (Bls, sense:
5'AGATGAAGTTCAGTCAATGG3' and Bla, antisense: 5'ATATTATAACTCATCGACAG3') were designed according to positions 27-46 and 1533-1552 of an S. pombe cDNA sequence encoding a protein homologous to
rat and mouse GII
(GenBankTM accession number D89245). A
PCR reaction using S. pombe genomic DNA as template yielded
a fragment of approximately 1,800 bp, which was larger than the
expected size of 1,526 bp. The 1,800-bp fragment was cloned in pGEMT
vector, and approximately 200 bp from both ends were sequenced. The
sequences corresponded to those of the D89245 sequence. This indicated
the presence of at least one intron. Reverse transcriptase-PCR was
performed on total S. pombe RNA using primer Bla for reverse
transcription and the same primer and Bls for PCR. A single 1,526-bp
band was obtained, thus confirming the presence of introns. To
facilitate introduction of the ura4+ marker gene
in the 1,526-bp fragment, two primers were designed according to the
D89245 sequence (BaHindIII, positions 595-614, antisense:
5'AATCCGTTGAAAGCTTCATC3' and BsHindIII, positions 592-611, sense: 5'GAAGATGAAGCTTTCAACGG3'). These primers introduce a
HindIII site through a G-T substitution. Two PCRs were then
performed using S. pombe cDNA as template and either
primers Bls and BaHindIII or Bs HindIII and Bla
to obtain fragments N (588 bp) and C (961 bp), respectively. Both were
separately cloned in pGEMT. Band N was liberated from the vector with
SacII (site in the vector) and HindIII (site in
the insert). The C-containing vector (pGEMT-C) was linearized with the
same enzymes. Fragment N was then ligated to linearized pGEMT-C to form
pGEMT-NC. This vector has a point mutation in position 577 of the
insert that introduces the single HindIII site in the
construct. This was linearized with HindIII and ligated to
the ura4+ gene. The ura4+
had been liberated from pBluescript with the same enzyme. The DNA
fragment containing the GII
-encoding fragment interrupted with
ura4+ (3,290 bp) was liberated from the vector
with NotI and transfected into strain SpAD: h
,
ura4-D18, leu1-32, ade6-M210, kindly
provided by Angel Durán, University of Salamanca, Spain.
Transformants (ura4+) were selected in plates with minimal
medium supplemented with Ade and Leu. Resulting strain was called
SpADII
. Its genotype was h
, ura4-D18,
leu1-32, ade6-M210,
gls2
::ura4+. PCRs
performed on 5 independent transformant colonies using sense and
antisense primers, respectively, complementary to the 1,526-bp
gls2
+ fragment (primer Bls) and to
ura4+ (primer UraAN, 5'TTTTCATCCCCTCAGCTC3')
yielded, in 4 colonies, fragments that were larger than the expected
1,180-bp fragment. This indicated that in those cells homologous
recombination had occurred downstream of the intron in genomic DNA. The
fifth colony and the construct yielded fragments of the expected size.
This indicated that in this single colony recombination had occurred upstream of the intron in genomic DNA or, alternatively, that a
non-homologous recombination had occurred. No fragment was synthesized when wild type DNA was used as template. The existence of the intron in
4 colonies and its absence in one of them was confirmed by Southern
blotting analysis. Genomic DNAs from wild type cells, from the putative
intron-containing mutants, and from the putative intron-free mutant
were digested with BglI and NcoI. The probe used
for Southern analysis consisted of two 192- and 260-bp
gls2
+ fragments that were contiguous in wild
type DNA but that were flanking the 5' and 3' ends of
ura4+, respectively, in the construct used for
gene disruption. They were generated by digestion of pGEMT-NC with
XhoI and HindIII. The expected fragment sizes in
wild type, intron-containing, and intron-free mutant DNAs were about
1000 (746 plus intron), 2780 (2510 plus intron), and 2510 bp,
respectively. Those were precisely the sizes found.
-mannosidase, dithiothreitol, protein
A-Sepharose, and endo-
-N-acetylglucosaminidase H (Endo H)
were from Sigma. Anti-S. pombe carboxypeptidase Y (CPY)
serum was a generous gift from Dr. K. Takegawa, Kagawa University, Japan.
-mannosidase generated
[glucose-14C]Glc2Man4GlcNAc.
-mannosidase were as described
previously (8). Short term (15 min) in vivo labeling of
S. pombe cells with [14C]glucose and
purification of labeled Endo H-sensitive oligosaccharides were
performed as described previously (8) for S. cerevisiae cells, but 100 µCi of [14C]glucose and no
1-deoxynojirimycin were used. For pulse-chase labeling, cells were
incubated with [14C]glucose for 60 min after which 1 M unlabeled glucose up to a 0.1 M final
concentration was added, and incubation was prolonged for an additional
30 min. Where indicated dithiothreitol up to a 5 mM final
concentration was added 5 min before addition of [14C]glucose. Pulse-chase labeling of cells with
[35S]Met and [35S]Cys as well as CPY
immunoprecipitations were performed as already described (22). Whatman
1 papers were used for chromatographies (8). Solvents employed were as
follows: solvent A, 1-propanol/nitromethane/water (5:2:4),
or solvent B, 1-butanol/pyridine/water (10:3:3). GI and GII activities were assayed as described previously (23) using [glucose-14C]Glc3Man9GlcNAc
and
[glucose-14C]Glc1Man7-9GlcNAc
as substrates, respectively.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
and gls2
Mutant
Strains--
As mentioned above, it was proposed that in mammalian
tissues GII is composed by two subunits, called GII
and GII
,
respectively, responsible for the catalytic activity and the ER
retention of the first subunit (14, 15). To verify this proposal the
genes that are homologous to those encoding GII
and GII
subunits
in mammalian cells were identified and individually disrupted in S. pombe. The GII
-encoding gene (here called
gls2
+) was disrupted, and the mutant was
genetically characterized as described previously (13, 20) for
construction of the gls2/alg6 double mutant. We have now
sequenced the 3' end of gls2
+ and verified
that S. pombe gls2
p (GII
) lacks, as its mammalian counterpart, an ER retrieval signal as it ends with PQLFLV (see "Experimental Procedures"). The GII
-encoding gene (here called gls2
+) was disrupted and genetically
characterized as described under "Experimental Procedures." It is
worth mentioning that gls2
p displays a signal peptide and an ER
retrieval sequence (VDEL) at its N and C termini, respectively.
and gls2
Cells--
Microsomes prepared from wild type and mutant cells were
incubated with either
[glucose-14C]Glc3Man9GlcNAc
or
[glucose-14C]Glc1Man7-9GlcNAc
to probe for GI and GII activities, respectively. Results depicted in
Fig. 1, A and B,
show that labeled glucose units were liberated from
Glc3Man9GlcNAc by wild type,
gls2
, and gls2
microsomes. On the other
hand, microsomes from wild type but not from mutant strains liberated
glucose from Glc1Man7-9GlcNAc (Fig.
1C). These results showed, therefore, that cells from both mutant strains displayed GI but not GII activity.

View larger version (15K):
[in a new window]
Fig. 1.
Cell-free determination of GI and GII
activities. Microsomes from wild type (open circles),
gls2
(filled circles), and gls2
(gray circles) cells were incubated with
[glucose-14C]Glc3Man9GlcNAc
(A and B) or with
[glucose-14C]Glc1Man7-9GlcNAc
(C). Ordinates represent the percentages of glucose
liberated. One hundred percent corresponds to 1200 cpm.
and gls2
mutant cells were pulsed
for 15 min with [14C]glucose. Total cell proteins were
degraded with an unspecific protease, and Endo H-sensitive
oligosaccharides were released from glycopeptides thus obtained. The
wild type strain mainly yielded substances that migrated on paper
chromatography as Man8GlcNAc and Man9GlcNAc
standards (Fig. 2A). Strong
acid hydrolysis of substances migrating as either one of the standards
only yielded labeled mannoses (not shown).

View larger version (18K):
[in a new window]
Fig. 2.
Patterns of protein-linked
oligosaccharides. Wild type (WT) (A),
gls2
(B), and gls2
(C) cells were incubated with [14C]glucose for
15 min. Total cell proteins were degraded with an unspecific protease,
and Endo H-sensitive oligosaccharides were liberated from glycopeptides
thus formed. Oligosaccharides were then run on paper chromatography
with solvent A. Standards are as follows:
2, Glc2Man9GlcNAc;
1, Glc1Man9GlcNAc; 9, Man9GlcNAc; and 8, Man8GlcNAc.
than in gls2
cells (Fig.
2, B and C). Strong acid hydrolysis of either one
of oligosaccharides synthesized by both mutant cells yielded glucose
and mannose units. The monosaccharide patterns yielded by substances
that migrated as the Glc2Man9GlcNAc standard in
Fig. 2, B and C, are depicted in Fig.
3, A and B,
respectively. Exhaustive
-mannosidase treatment of compounds that
migrated as Glc2Man9GlcNAc and
Glc1Man9GlcNAc standards synthesized by gls2
cells yielded, for both oligosaccharides, a compound
that migrated as a Glc2Man4GlcNAc standard,
differently from both Glc1Man4GlcNAc and
Glc1Man5GlcNAc standards (Fig. 3, C
and D, respectively). This indicated that the compound that
migrated as a Glc1Man9GlcNAc standard in Fig.
2B was Glc2Man8GlcNAc. Results shown
in Figs. 2 and 3 indicate, therefore, that in gls2
cells
only the external glucose unit was removed from the transferred
oligosaccharide (Glc3Man9GlcNAc2)
and that in some cases a mannose residue was also excised. The mutant
cells were, therefore, totally unable to form in vivo
monoglucosylated oligosaccharides either by partial deglucosylation of
Glc3Man9GlcNAc2 or by
reglucosylation of glucose-free compounds.

View larger version (28K):
[in a new window]
Fig. 3.
Characterization of oligosaccharides, monosaccharide composition, and
-mannosidase degradation. Saccharides that
migrated as the Glc2Man9GlcNAc standard in Fig.
2B (gls2
cells) (A) and in Fig.
2C (gls2
cells) (B) were submitted
to strong acid hydrolysis followed by paper chromatography with solvent
B. Standards are as follows: 1, mannose;
2, glucose; and 3, galactose. Saccharides that
migrated as the Glc2Man9GlcNAc standard in Fig.
2B (gls2
cells) (C) and Fig.
2C (gls2
cells) (E) were treated
with
-mannosidase and run on paper chromatography with solvent
A. Saccharides that migrated as the
Glc1Man9GlcNAc standard in Fig. 2B
(gls2
cells) (D) and Fig. 2C
(gls2
cells) (F) were similarly treated.
Standards are as follows: 4, Glc1Man4GlcNAc; 5, Glc2Man4GlcNAc; and 6, Glc1Man5GlcNAc.
-mannosidase treatment of the oligosaccharide
synthesized by gls2
cells that migrated as a
Glc2Man9GlcNAc standard (Fig. 2C)
yielded the same as that synthesized by gls2
cells, a
compound that migrated as a Glc2Man4GlcNAc
standard (Fig. 3E), but the compound that migrated as a
Glc1Man9GlcNAc standard in Fig. 2C
yielded, with the same enzymatic treatment, compounds that migrated as
Glc2Man4GlcNAc and
Glc1Man4GlcNAc standards (Fig. 3F).
This indicated that the compound that migrated as a
Glc1Man9GlcNAc standard in Fig. 2C
was a mixture of Glc2Man8GlcNAc and
Glc1Man9GlcNAc.
p
(GII
) is the catalytic subunit of GII as absolutely no GII activity was detected in both in vitro and in vivo assays
in gls2
mutants. On the other hand, gls2
p (GII
)
represents a subunit that retains gls2
p (GII
) in the ER, as the
extremely low GII activity that could be detected in in vivo
but not in in vitro assays in gls2
cells
probably represented gls2
p that was transiently present in the ER
before secretion.
cells at 18, 28, and 39 °C were observed. In addition, no
morphological differences were observed between both strains under a
light microscope.
) or partially (UDP-Glc:glycoprotein
glucosyltransferase null, called gpt1) prevented would show
an accumulation of misfolded glycoproteins bearing ER-specific
oligosaccharides. Wild type and mutant cells were incubated for 60 min
in the presence of minute amounts of [14C]glucose
followed by a 30-min chase with an excess of the unlabeled monosaccharide to allow Golgi elongation of secreted (properly folded)
glycoprotein molecules. Different patterns of protein-linked oligosaccharides were obtained in wild type and mutant cells. Whereas
in the former cells Man9GlcNAc2 and
Man8GlcNAc2 represented a small proportion of
the protein-linked oligosaccharides (Fig. 4A), in both
gls2
and gpt1 mutants the ER-specific
oligosaccharides (Glc2Man9GlcNAc2 and
Glc2Man8GlcNAc2 in
gls2
and Man9GlcNAc2 and
Man8GlcNAc2 in gpt1) were the main
compounds present.

View larger version (23K):
[in a new window]
Fig. 4.
Pulse-chase incubations of wild type
(WT), gls2
, and gpt1
cells. Wild type (A and D),
gls2
(B), and gpt1 (C)
cells were incubated with [14C]glucose for 60 min
followed by a 30-min chase with an excess of the unlabeled
monosaccharide. Endo H-liberated oligosaccharides were run on paper
chromatography with solvent A. D, 5 mM dithiothreitol (DTT) was added 5 min before
the label. Standards are as follows: 2, Glc2Man9GlcNAc; 1, Glc1Man9GlcNAc; 9, Man9GlcNAc; and 8, Man8GlcNAc.
, gls2
, and
gpt1 Mutant Strains--
Accumulation of misfolded proteins in the
S. pombe ER leads to the so called unfolded protein
response, that is to the induction of mRNAs coding for chaperones
and other proteins that facilitate proper folding of recently
synthesized species (9-11, 26). If monoglucosylated oligosaccharides
were involved in glycoprotein folding facilitation as indicated by the
model proposed for the quality control of glycoprotein folding, it
would be expected that an increased synthesis of folding facilitating
proteins would occur in gls2
, gls2
, and
gpt1 cells grown under non-stressed conditions.
, gls2
, and gpt1 cells grown
in the absence of exogenous stress (28 °C in a rich medium). It has
been reported that in S. pombe, accumulation of misfolded
species in the ER triggers synthesis of two BiP mRNAs, one of them
having the same size as the only one present in wild type cells grown
under normal conditions and the other having a slightly smaller size
(26). Northern blotting analysis of total mRNA using a portion of
the BiP-encoding gene as probe revealed two bands in gls2
, gls2
, and gpt1 but only one in wild type cells (Fig.
5A). Results were scanned, and intensities obtained for BiP mRNAs were normalized with those obtained for actin mRNA. Ratios obtained for wild type cells were taken as 1. In three independent experiments the ratios of BiP/actin mRNAs were 1.8, 2.6, and 2.2 for gls2
and 2.4, 2.7, and 2.1 for gpt1 cells. In two experiments, the ratios
obtained for gls2
cells were 2.1 and 2.2 (Fig.
5B).

View larger version (40K):
[in a new window]
Fig. 5.
Expression of BiP-encoding mRNA in wild
type and mutant cells. A, wild type (WT),
gls2
, gls2
, and gpt1 cells were
grown in YE medium at 28 °C, and mRNA was extracted and
submitted to Northern blotting analysis. Both larger signals correspond
to BiP mRNAs and the smaller ones to actin (Act)
mRNAs. B, results shown in A were scanned in
less exposed photos in order to ensure the proportionality of the
intensities. The ratios of BiP/actin mRNAs intensities obtained are
represented in the ordinates. The value obtained for wild
type cells was taken as 1.
mutants) or reduced levels of them
(gls2
mutants) were formed or in cells in which
monoglucosylated oligosaccharides were not formed by GT-mediated
reglucosylation (gpt1 mutants).
Cells--
It
has been reported that interaction with calnexin/calreticulin delays
folding velocity but increases folding efficiency of hemagglutinin
translated in a rabbit reticulocyte-dog pancreas microsome system (6).
To test if the same occurs in S. pombe, intact wild type and
gls2
cells were pulsed with [35S]Met and
[35S]Cys for 5 min. Samples were then withdrawn after
different chase periods, and S. pombe CPY was
immunoprecipitated from them. It has been reported that the ER form of
S. pombe CPY is a 110-kDa protein that is proteolytically
processed in the vacuole to a 51-kDa species (22). This in turn is
formed by two polypeptides of 19 and 32 kDa held together by a
disulfide bridge. The antiserum specifically recognized the latter
fragment. Immunoprecipitates were submitted to SDS-polyacrylamide gel
electrophoresis under reducing conditions followed by autoradiography.
The gels were scanned and intensities of the 32-kDa fragment were
normalized relative to amount of label precipitated by 10%
trichloroacetic acid from each sample.
cells were taken as 100%. It may be
observed that CPY arrived faster to the vacuole in gls2
than in wild type cells. On the other hand, in Fig. 6B the
relative intensity of the 30-min sample of wild type cells was taken as
100% for samples obtained from either wild type or gls2
cells. It may be observed that the amount of CPY that arrived to the
vacuole in wild type cells was approximately double than that in
gls2
mutants. It may be concluded, therefore, that as
described for mammalian cells also in intact S. pombe cells
formation of monoglucosylated oligosaccharides reduces the folding rate
and increases folding efficiency (6).

View larger version (13K):
[in a new window]
Fig. 6.
CPY processing in wild type and
gls2
cells. Wild type and gls2
cells were pulsed for 5 min with [35S]Met and
[35S]Cys and chased for the indicated times. CPY was
immunoprecipitated and run on 10% SDS-polyacrylamide gel
electrophoresis under reducing conditions. Autoradiographies were
scanned and intensities normalized respective to label precipitated by
10% trichloroacetic acid from each sample. A, the relative
intensities of the 30-min chase samples of either wild type
(filled circles) or gls2
(open
circles) cells were taken as 100%. B, the relative
intensity of the wild type cell 30-min chase sample was taken as 100%
for all samples.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
) and ER retention (GII
) subunits (14,
15). This proposal remained controversial as such structure was
detected in mouse T-lymphoma cell and rat liver enzyme preparations but
not in GII purified to homogeneity from plants and pig liver and kidney
(16-18). In addition, although the GII
homolog in S. cerevisiae also lacks an ER retrieval sequence and shows
significant similarity to its mammalian counterpart, no protein with
significant homology to GII
and having an ER retrieval sequence was
found in the budding yeast genome (14). The possibility exists,
therefore, that the heterodimeric structure could be restricted to
mouse and rat tissues or, alternatively, that it could be an artifact created during enzyme purification.
or GII
homologs in S. pombe were disrupted, and no GII activity was detected in in vitro assays performed with microsomal fractions isolated from the
respective mutants. On the other hand, GI activity in both mutant
microsomal fractions had levels similar to those found in wild type
cells. Despite the total absence of GII activity revealed by in
vitro assays, structural analysis of protein-linked oligosaccharides synthesized in intact wild type and mutant cells pulsed with [14C]glucose confirmed that GII
is indeed
responsible for catalysis and GII
for GII
ER retention; although
Glc2Man9GlcNAc2 and
Glc2Man8GlcNAc2 were the only
compounds synthesized in the gls2
mutant, formation of
small amounts of Glc1Man9GlcNAc2
was detected in gls2
cells. It may be speculated that the
latter compound was formed by gls2
p transiently present in the ER
before secretion. The notion that gls2
p (GII
) is the catalytic
subunit agrees with the fact that it shows significant similarity to
the so-called family 31 and 9 glucosidases (27). Although GII
displays an ER retrieval sequence (VDEL) and as such its primary role
is probably that of retaining GII
in the ER, it cannot be discarded
that it might also contribute to the stability of the latter subunit.
It is worth mentioning that a GII
homolog has been detected also in the human genome (14, 15). This fact as well as results presented in
the present report strongly suggest that GII is a heterodimer in most
if not all eukaryotic cells. The presence of ER-retaining subunits has
been already described for prolyl 4-hydroxylase and the triglyceride
transfer proteins that lack ER retrieval signals (28, 29). In both
cases the retaining protein (protein disulfide isomerase) is essential
for cell viability, thus precluding confirmation of its retaining role
by gene disruption.
and GII
are
minor lumenal ER proteins, so their absence is not expected to trigger the unfolded protein response for unspecific reasons. Nevertheless, gls2
and gls2
mutant cells grown in the
absence of exogenous stress accumulated misfolded proteins in the ER as
judged by the induction of BiP-encoding mRNA. That misfolding of
glycoproteins (and therefore BiP induction) in gls2
and
gls2
mutants was not caused by a deleterious effect of
the two retained glucoses on the tertiary structure of the protein
moieties but by a deficiency in the formation of monoglucosylated
oligosaccharides was also indicated by the fact that the unfolded
protein response was observed in gpt1 mutants, that is in
cells that lacked GT-mediated reglucosylation. No diglucosylated
oligosaccharides accumulated in those mutant cells. Induction of
BiP-encoding mRNA in the absence of exogenous stress was shown to
occur also in GII-defective mammalian cells (31). However, it cannot be
concluded that BiP mRNA induction in the latter cells was an
exclusive consequence of the lack of GII because those mutants had been
obtained by selecting cells resistant to Phaseolus vulgaris
leukoagglutinin after treatment with chemical mutagens (32, 33). On the
contrary, Southern blotting analysis of all mutants employed in the
present report (gls2
, gls2
, and
gpt1) showed that the marker gene employed (ura4+) had always only disrupted the intended
target. Misfolding glycoproteins in cells deficient in monoglucosylated
oligosaccharide formation was also revealed by the much higher
proportion of ER-specific, protein-linked oligosaccharides detected in
gls2
and gpt1 mutants when compared with wild
type cells.
than to those of wild
type cells. This result and the already mentioned accumulation of
misfolded glycoproteins in the ER of cells grown under non-stressed
conditions but having impaired formation of monoglucosylated
oligosaccharides confirm that those compounds are indeed involved in
glycoprotein folding facilitation in S. pombe. The absence
of a discernible phenotype in gls2
, gls2
,
and gpt1 cells may be explained by the up-regulation of BiP
and probably of other chaperones and folding-assisting proteins that
compensate for the null or lower amount of monoglucosylated
oligosaccharides formed. As mentioned above, only under extreme stress
conditions (glycoprotein underglycosylation and high temperature) the
formation of monoglucosylated glycoproteins was found to be required
for S. pombe viability (13).
![]()
FOOTNOTES

Career Investigator of the National Research Council
(Argentina) and a Howard Hughes Medical Institute International
Research Scholar. To whom correspondence should be addressed: Instituto de Investigaciones Bioquímicas Fundación Campomar,
Antonio Machado 151, 1405 Buenos Aires, Argentina. Tel.: 54-11 4863-4011; Fax: 54-11 4865-2246; E-mail: aparodi@iib.uba.ar.
![]()
ABBREVIATIONS
-N-acetylglucosaminidase H;
ER, endoplasmic
reticulum;
GI, glucosidase I;
GT, UDP-Glc:glycoprotein
glucosyltransferase;
PCR, polymerase chain reaction;
bp, base
pair.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Parodi, A. J.,
Mendelzon, D. H.,
and Lederkremer, G. Z.
(1983)
J. Biol. Chem.
258,
8260-8265 2.
Trombetta, S.,
Bosch, M.,
and Parodi, A. J.
(1989)
Biochemistry
28,
8108-8116[CrossRef][Medline]
[Order article via Infotrieve]
3.
Helenius, A.,
Trombetta, E. S.,
Hebert, D. N.,
and Simons, J. F.
(1997)
Trends Cell Biol.
7,
193-200
[Medline]
[Order article via Infotrieve] 4.
Sousa, M.,
Ferrero-García, M.,
and Parodi, A. J.
(1992)
Biochemistry
31,
97-105[CrossRef][Medline]
[Order article via Infotrieve]
5.
Zhang, J.-X.,
Braakman, I.,
Matlack, K. E. S.,
and Helenius, A.
(1997)
Mol. Biol. Cell
8,
1943-1954 6.
Hebert, D. N.,
Foellmer, B.,
and Helenius, A.
(1996)
EMBO J.
15,
2961-2968[Medline]
[Order article via Infotrieve]
7.
Vassilakos, A.,
Cohen-Doyle, M. F.,
Peterson, P. A.,
Jackson, M. R.,
and Williams, D. B.
(1996)
EMBO J.
15,
1495-1506[Medline]
[Order article via Infotrieve]
8.
Fernández, F.,
Trombetta, S. E.,
Hellman, U.,
and Parodi, A. J.
(1994)
J. Biol. Chem.
269,
30701-30706 9.
Fernández, F.,
Jannatipour, M.,
Hellman, U.,
Rokeach, L.,
and Parodi, A. J.
(1996)
EMBO J.
15,
705-713[Medline]
[Order article via Infotrieve]
10.
Jannatipour, M.,
and Rokeach, L. A.
(1995)
J Biol. Chem.
270,
4845-4853 11.
Parlati, F.,
Dignard, D.,
Bergeron, J. J.,
and Thomas, D. Y.
(1995)
EMBO J.
14,
3064-3072[Medline]
[Order article via Infotrieve]
12.
Ziegler, F. D.,
Gemmil, T. R.,
and Trimble, R. B.
(1994)
J. Biol. Chem.
268,
12527-12535
13.
Fanchiotti, S.,
Fernández, F.,
D'Alessio, C.,
and Parodi, A. J.
(1998)
J. Cell Biol.
143,
625-635 14.
Trombetta, E. S.,
Simons, J. F.,
and Helenius, A.
(1996)
J. Biol. Chem.
271,
27509-27516 15.
Arendt, C. W.,
and Ostergaard, H. L.
(1997)
J. Biol. Chem.
272,
13117-13125 16.
Brada, D.,
and Dubach, U. C.
(1984)
Eur. J. Biochem.
141,
149-156[Medline]
[Order article via Infotrieve]
17.
Kaushal, G. P.,
Pastuszak, I.,
Hatanaka, K.,
and Elbein, A. D.
(1990)
J. Biol. Chem.
265,
16271-16279 18.
Flura, T.,
Brada, D.,
Ziak, M.,
and Roth, J.
(1997)
Glycobiology
7,
617-624 19.
Moreno, S.,
Klar, A.,
and Nurse, P.
(1991)
Methods Enzymol.
194,
795-823[Medline]
[Order article via Infotrieve]
20.
Fernández, F.,
D'Alessio, C.,
Fanchiotti, S.,
and Parodi, A. J.
(1998)
EMBO J.
17,
5877-5886[CrossRef][Medline]
[Order article via Infotrieve]
21.
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
22.
Tabuchi, M.,
Iwahara, O.,
Ohtani, Y.,
Ohuchi, N.,
Sakurai, J.-I.,
Morita, T.,
Iwahara, S.,
and Takegawa, K.
(1997)
J. Bacteriol.
179,
4179-4189 23.
Ugalde, R. A.,
Staneloni, R. J.,
and Leloir, L. F.
(1979)
Biochem. Biophys. Res. Commun.
91,
1174-1181[Medline]
[Order article via Infotrieve]
24.
Jamsa, E.,
Simonen, M.,
and Makarow, M.
(1994)
Yeast
10,
355-370[CrossRef][Medline]
[Order article via Infotrieve]
25.
Simons, J. F.,
Ferro-Novick, S.,
Rose, M. D.,
and Helenius, A.
(1995)
J. Cell Biol.
130,
41-49 26.
Pidoux, A. L.,
and Armstrong, J.
(1992)
EMBO J.
11,
1583-1591[Medline]
[Order article via Infotrieve]
27.
Henrissat, B.
(1991)
Biochem. J.
280,
309-316
28.
Pihlahaniemi, T.,
Helaakoski, T.,
Tasanem, K.,
Myllyla, R.,
Huhtala, M. L.,
Koivu, J.,
and Kivirikko, K. I.
(1987)
EMBO J.
6,
643-649[Medline]
[Order article via Infotrieve]
29.
Gordon, D.,
Wetterau, J.,
and Gregg, R.
(1995)
Trends Cell Biol.
5,
317-321
[CrossRef][Medline]
[Order article via Infotrieve] 30.
Petrescu, A. J.,
Butters, T. D.,
Reinkensmeier, G.,
Petrescu, S.,
Platt, F. M.,
Dwek, R. A.,
and Wormald, M. R.
(1997)
EMBO J.
16,
4302-4310[CrossRef][Medline]
[Order article via Infotrieve]
31.
Balow, J. P.,
Weissman, J. D.,
and Kearse, K. P.
(1995)
J. Biol. Chem.
270,
29025-29029 32.
Reitman, M. L.,
Trowbridge, I. S.,
and Kornfeld, S.
(1982)
J. Biol. Chem.
257,
10357-10363 33.
Trowbridge, I. S.,
Hyman, R.,
Ferson, T.,
and Mazauskas, C.
(1978)
Eur. J. Immunol.
8,
716-723[Medline]
[Order article via Infotrieve]
34.
Jakob, C. A.,
Burda, P.,
te Heesen, S.,
Aebi, M.,
and Roth, J.
(1998)
Glycobiology
8,
155-164 35.
Simons, J. F.,
Ebersold, M.,
and Helenius, A.
(1998)
EMBO J.
17,
396-405[CrossRef][Medline]
[Order article via Infotrieve]
36.
Vassilakos, A.,
Michalak, M.,
Lehrman, M. A.,
and Williams, D. B.
(1998)
Biochemistry
37,
3480-3490[CrossRef][Medline]
[Order article via Infotrieve]
37.
Parlati, F.,
Dominguez, M.,
Bergeron, J. J.,
and Thomas, D. Y.
(1995)
J. Biol. Chem.
270,
244-253
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. J. Caramelo and A. J. Parodi Getting In and Out from Calnexin/Calreticulin Cycles J. Biol. Chem., April 18, 2008; 283(16): 10221 - 10225. [Full Text] [PDF] |
||||
![]() |
C.-M. Cruciat, C. Hassler, and C. Niehrs The MRH Protein Erlectin Is a Member of the Endoplasmic Reticulum Synexpression Group and Functions in N-Glycan Recognition J. Biol. Chem., May 5, 2006; 281(18): 12986 - 12993. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Reyes, L. Marchant, L. Norambuena, R. Nilo, H. Silva, and A. Orellana AtUTr1, a UDP-glucose/UDP-galactose Transporter from Arabidopsis thaliana, Is Located in the Endoplasmic Reticulum and Up-regulated by the Unfolded Protein Response J. Biol. Chem., April 7, 2006; 281(14): 9145 - 9151. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Wilkinson, J. Purswani, and C. J. Stirling Yeast GTB1 Encodes a Subunit of Glucosidase II Required for Glycoprotein Processing in the Endoplasmic Reticulum J. Biol. Chem., March 10, 2006; 281(10): 6325 - 6333. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schirawski, H. U. Bohnert, G. Steinberg, K. Snetselaar, L. Adamikowa, and R. Kahmann Endoplasmic Reticulum Glucosidase II Is Required for Pathogenicity of Ustilago maydis PLANT CELL, December 1, 2005; 17(12): 3532 - 3543. [Abstract] [Full Text] [PDF] |